Popular Searches
Skip to content

Associate Professor

Department of Social, Behavioral, and Administrative Sciences

Touro College of Pharmacy

Contact

Dr. Kumar Mukherjee brings over fifteen years of experience in academic pharmacy, complemented by two years of experience in pharmaceutical industry specializing in oncology outcomes research. He joined us with a robust background in health outcomes, pharmacoeconomics, and application of statistical principles in healthcare data. He has taught courses in pharmacoeconomics and health outcomes, research methods, biostatistics, healthcare data modeling, and pharmacoepidemiology. 

 

Education

Ph.D. Pharmaceutical Outcomes and Policy Research, University of Florida, Gainesville, July 2008
MS, Pharmacy Administration, University of Toledo, Ohio, June 2004
Post Graduate Diploma in Management, T A Pai Management Institute, Manipal, India, May 2000
Bachelor of Pharmacy, Jadavpur University, Kolkata, India, May 1998

Areas of Expertise

Health outcomes and policy research, Pharmacoeconomics, Statistical methods and applications in healthcare data

Honors and Awards

ISPOR Distinguished Service Award in recognition of service to society 2021-2024

Teacher of the Year award - College of Pharmacy, Chicago State University.

Alumni Fellowship (Highest Graduate Student Award), University of Florida, Graduate School for 2004 – 2008.

Best International Graduate Student Award, awarded by the College of Pharmacy of the University of Florida

Research

His research focuses on leveraging national level secondary databases such as medical claims, national surveys, and electronic health records, to explore health outcomes and epidemiological research in different disease states including cancer.

Recent Publications

Recent Peer-Reviewed Publications:

  1. Jung J, Mukherjee K, Brown M, Sadigh G. Association between financial hardship and psychological burden and the role of social and mental health support: An observational study. Medicine (Baltimore). 2024 Jul 12;103(28):e38871. doi: 10.1097/MD.0000000000038871. PMID: 38996144; PMCID: PMC11245238.
  2. Mukherjee K, Gunsoy NB, Kristy RM et al. Handling missing data in Health Economics and Outcomes Research (HEOR): A systematic review and practical recommendations. PharmacoEconomics, 2023, https://doi.org/10.1007/s40273-023-01297-0
  3. Chen Y, Roy RC, Roy A, Mukherjee K. Association between socio-demographic and clinical factors and health outcomes among Covid-19 patients in a community hospital in Alabama. J Community Med Public Health, 2023, 7:327. DOI: https://doi.org/10.29011/2577-2228.100327
  4. Mukherjee K, Elsayed M, Choksi E, Loya MF, Duszak R Jr., Akce M, et al. Use of Metformin and Survival in Patients with Hepatocellular Carcinoma (HCC) Undergoing Liver Directed Therapy: Analysis of a Nationwide Cancer Registry. CardioVasc Intervent Radiol. 2023 July; 46(7):870-879. DOI: 1007/s00270-023-03467-1
  5. Choksi E, Mukherjee K*, Sadigh G, Duszak R. Out-of-pocket expenditures for imaging examinations: Perspectives from national patient surveys over two decades. Journal of the American College of Radiology, 2023, 20(1): 18-28 https://doi.org/10.1016/j.jacr.2022.07.014 *Corresponding author
  6. Choksi E, Mukherjee K*, Khalid K, Salazar R, Yocom S. Length of stay, cost and outcomes related to traumatic subdural hematoma in inpatient setting in the United States. Brain Injury, 2022, 36:10-11,1237-1246. https://doi.org/10.1080/02699052.2022.2110285   *Corresponding author
  7. Mukherjee K. Propensity score monograph. ISPOR. Available at the URL: propensity-score-monograph.pdf (ispor.org)
  8. Mukherjee K*, Davisson N, Malik S, Duszak R, Kokabi N. National Utilization, Survival, and Cost Analyses of Treatment Options for Stage 1 NonSmall Cell Lung Cancer: A SEER-Medicare Database Analysis. Acad Radiol. 2022 Feb; 29 Suppl 2:S173-S180. doi: 1016/j.acra.2021.07.009. Epub 2021 Aug 14. PMID: 34404607. * First and corresponding author
  9. Mukherjee K*, Small William Jr., Duszak R. Trends and Variations in Utilization and Costs of Radiotherapy for Prostate Cancer: A SEER Medicare Analysis from 2007 through 2016. 2022 Jan-Feb;21(1):12-21. doi: 10.1016/j.brachy.2021.06.148. * First and corresponding author
  10. Gozebakan KC, *Mukherjee K, Berry EG, Sonmez K, Leachman SA, Etzioni R. Impact of novel systemic therapies on the first-year costs of care for melanoma among Medicare beneficiaries. Cancer, August 2021, 127(16): 2926-2933. * Joint first author
  11. Reece M, Hola L, Mukherjee K. Survey of Pharmacists’ knowledge of Connecticut’s Medical Cannabis program. Cannabis and Cannabinoid Research. Feb 2021, 6(1):66-73. https://doi.org/10.1089/can.2019.0013

McGee E, Mukherjee K. Assessment of using structured classroom debate to teach an antimicrobial stewardship elective course. Accepted for publication in Currents in Pharmacy Teaching and Learning. February 2020, 12(2): 220-2

Invited Presentations:

  1. ISPOR International conference, 2024. Statistics in HEOR Special Interest Group – External Control Arm trials workshop
  2. ISPOR International conference, 2021. Title: Handling Missing Data in Health Economics and Outcomes Research – State of the Art Guidance and Good Practices
  3. West Virginia University, Department of Pharmaceutical Outcomes and Policy. Title: An Overview of SEER Medicare data.
  4. ISPOR student network, University of Houston: Title: Basics of Handling Uncertainty in Cost-Effectiveness Analysis

Recent Poster Presentations 

  1. Shore N, Orji C, Mukherjee K, O’Donnell L et al. Real-World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics. – Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, 2025, in Montreal, Canada. Role: Study contributor from AstraZeneca.
  2. Efstathiou E, Li W, Roose J, Kerr BT, Orji C, Yeh N, Corson S, Mukherjee K. Real-world treatment patterns in patients diagnosed with metastatic castration-resistant prostate cancer in the US, 2018-2023 – Poster presented at ASCO-GU conference 2025. Role: Study lead
  3. Jun J, Mukherjee K, Choksi EJ, Sadigh G. The association between patients’ medical financial hardship and psychosocial burden – Poster presented at the Academy Health Annual Research Meeting, Seattle, USA 2023.
  4. Siddiqui ZA, Kamal K, Mukherjee K. First-year Costs of Care Associated with Non-Small Cell Lung Cancer (NSCLC) Among Medicare Beneficiaries - Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, Boston, USA, 2023. This work is selected as one of the Top Six posters in the Oncology division and Top 5% of all poster presentations of the conference.
  5. Choksi E, Mukherjee K*, Gelareh S, Duszak R Jr. Out-of-pocket expenditure for imaging examinations: perspectives from national patient surveys over two decades. – Poster presented at the American College of Radiology annual conference 2022. *Corresponding author. Presentation won the Best Research Award in Advocacy, Economics and Health Policy section of the ACR conference 2022
  6. Mukherjee K, Duszak R Jr. Utilization and costs of non-invasive diagnostic imaging in Medicare patients with newly diagnosed lung cancer – Presented at the American College of Radiology annual conference 2022.
  7. Mukherjee K, Duszak R Jr. Utilization and costs of non-invasive diagnostic imaging in Medicare patients with newly diagnosed breast cancer – Presented at the American College of Radiology annual conference 2022.
  8. Choksi E, Mukherjee K, Kamal K, Yocom S, Salazar R. Length of stay, cost and outcomes related to traumatic subdural hematoma in inpatient setting in the United States. - Poster presented at the ISPOR Annual International Meeting, Washington DC, USA, 2022. Was selected among top 5% of all research posters submitted in the conference.
  9. Elsayed M, Choksi E, Mukherjee K et al. Use of metformin and survival in patients with hepatocellular carcinoma (HCC) undergoing liver directed therapy: A SEER-Medicare Analysis – Presented in Society of Interventional Radiology (SIR) annual conference in Boston USA, 2022.
  10. Mukherjee K, Small W Jr, Duszak R Jr, Trend and Disparities in utilization and costs of radiotherapy for prostate cancer: A SEER Medicare analysis from 2007 through 2016. – Presented at the American College of Radiology Annual Conference, 2021
  11. Davisson N, Mukherjee K, Duszak R Jr, Kokabi N. National utilization and survival analysis of treatment options for stage I non-small cell lung cancer: A SEER-Medicare database analysis. – Presented at Society of Interventional Radiology (SIR) annual conference in Seattle USA, 2020.

 

Professional Service

Member Engagement Chair 2021-2024 of Statistics in Health Economics and Outcomes Research (HEOR) Special Interest Group  of ISPOR.

Served in the HEOR Excellence- Methodology Award Selection Committee of ISPOR from 2023-2025

Reviewer of Research Abstract Submissions in: ISPOR International Conference, ISPOR European Conference, International Society of PharmacoEpidemiology (ISPE) International Conference.

Memberships and Affiliations

ISPOR, AACP

Teaching Responsibilities

SBAN 504 Healthcare Systems and Health Policies
SBAN 689 Pharmacoeconomics and Outcomes Research

Languages

English, Bengali, Hindi

Hobbies

Sports, Mathematics